Some health insurers gain, others fall as Trump elected US President for second term
** Shares of some U.S health insurers gain between 3% and 8% in premarket trade after Donald Trump elected U.S. president for a second term
** Humana HUM.N up 7.6%, while UnitedHealth UNH.N rises 6%, Cigna CI.N up 3.5% and Elevance ELV.N gains 3.3% before the bell
** J.P. Morgan analysts had said ahead of elections that a Trump win would be favorable for insurers that serve Medicare Advantage plans for people 65 years and older and would mean a "lighter-touch" M&A regime
** On the other hand, shares of Centene CNC.N, which offers Medicaid plans that cover low-income people, fall 4.5% to $61.90 and peer Molina Healthcare MOH.N down 5.2% at $316.15
** A Trump administration could push for reductions in funding, and changes to some payment integrity rules that help manage spending for Medicaid plans - J.P. Morgan analysts
** Shares of CVS Health CVS.N also up 2.5% at $56.77 premarket; CVS expected to report third-quarter earnings on Wednesday
** UNH up about 8%, CI up 6% and ELV up 5% YTD; HUM down 43%, CNC down ~13%, CVS down ~30% and MOH down ~8% YTD
Reporting by Bhanvi Satija in Bengaluru
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
